Barry Salzman

Barry Salzman joined VIVEX Biologics’ Board of Directors in January 2015. Mr. Salzman is currently a Managing Director for Compass Partners LLC, a merchant banking and financial advisory firm that specializes in middle market companies and corporate restructuring. He joined Compass Partners LLC in July 2007, the same time at which he became a Board Member and Principal owner of BP Gamma Medical Supply Company.

Prior to July 2007, Mr. Salzman served as Board Chairman, President, and principal owner of Becker-Parkin Dental Supply Company. After 20 years at Becker-Parkin, Mr. Salzman sold the company to Henry Schein Inc. (NASDAQ: HSIC). From 2008-2012, he served as President of Surgery Works LLC, which was formed by Compass Partners LLC to provide financial management services for ambulatory surgery centers. In 2012 the centers sold a controlling interest to Amsurg (NASDAQ: AMSG). Mr. Salzman has maintained board seats at former Surgery Works, LLC centers and continues to work in a consulting and advisory role to Amsurg.

In 2014, Mr. Salzman founded and became President of Practice Management Works LLC, and in 2016 he accepted a board seat at Checkpoint Therapeutics Inc. (CKPT), an immune-oncology biopharmaceutical company. Mr. Salzman is a 1987 graduate of Brooklyn Law School and is a member in good standing of the New York Bar Association.